Chung T D, Wymer J P, Smith C C, Kulka M, Aurelian L
Department of Pharmacology and Experimental Therapeutics, University of Maryland School of Medicine, Baltimore 21201.
J Virol. 1989 Aug;63(8):3389-98. doi: 10.1128/JVI.63.8.3389-3398.1989.
The large subunit of the herpes simplex virus type 2 (HSV-2) ribonucleotide reductase (RR1) is demonstrated to possess serine/threonine-specific kinase activity. Computer-assisted sequence analysis identified regions within the amino terminus of ICP10 that are homologous to the catalytic domain of known protein kinases (PKs). An in vitro kinase assay confirmed the ability of ICP10, immunoprecipitated from either HSV-2-infected cells or from cells transfected with an ICP10 expression vector, to autophosphorylate and transphosphorylate exogenous substrates in the presence of ATP and Mg2+. The HSV-1 RR1 was shown to be negative for PK activity under these conditions. PK activity was localized to a 57-kDa amino-terminal region within ICP10 that lacked RR activity.
已证实单纯疱疹病毒2型(HSV-2)核糖核苷酸还原酶(RR1)的大亚基具有丝氨酸/苏氨酸特异性激酶活性。计算机辅助序列分析确定了ICP10氨基末端内与已知蛋白激酶(PKs)催化结构域同源的区域。体外激酶测定证实,从HSV-2感染细胞或用ICP10表达载体转染的细胞中免疫沉淀的ICP10,在ATP和Mg2+存在下能够自磷酸化并转磷酸化外源底物。在这些条件下,HSV-1 RR1的PK活性显示为阴性。PK活性定位于ICP10内一个缺乏RR活性的57 kDa氨基末端区域。